Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2059-2065

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Huang, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Huang, P. L.
Related Collections
Right arrow Animal models of human disease
Right arrow Risk Factors
Right arrow Ischemic biology - basic studies
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2059-2065.)
© 1999 American Heart Association, Inc.


Vascular Biology

Estrogen Mediates the Protective Effects of Pregnancy and Chorionic Gonadotropin in a Mouse Model of Vascular Injury

Lin Zhang; Mark C. Fishman; Paul L. Huang
Abstract—To determine why pregnancy protects against intimal proliferation in a mouse model of vessel injury, we administered chorionic gonadotropin to intact and ovariectomized female mice. Chorionic gonadotropin markedly suppressed intimal proliferation in intact but not in ovariectomized female mice, indicating that the protective effects of chorionic gonadotropin require ovarian function. To test whether estrogen or progesterone might mediate the protective effects of pregnancy and chorionic gonadotropin, we administered estrogen and progesterone to ovariectomized mice. Estrogen administration to ovariectomized mice to achieve the elevated levels seen in pregnancy was sufficient to reproduce the marked suppression of intimal proliferation in response to vessel injury. Progesterone administration reduced intimal proliferation to a lesser degree and was correlated with increases in estrogen to levels seen in nonpregnant female mice. Staining for proliferating cell nuclear antigen suggested that estrogen reduced medial and intimal cell proliferation. Both the classic estrogen receptor-{alpha} and the recently discovered estrogen receptor-ß are present in vascular tissue as assessed by immunohistochemistry, providing a possible mechanism for the effects of estrogen. These results suggest that the protective effects of estrogen do not plateau at levels seen in normal females but increase further with estrogen levels up through levels seen during pregnancy.


Key Words: vascular endothelium • atherosclerosis • estrogen • sex • pregnancy




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
V. W.T. Liu and P. L. Huang
Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice
Cardiovasc Res, January 1, 2008; 77(1): 19 - 29.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Delpy, V. Douin-Echinard, L. Garidou, C. Bruand, A. Saoudi, and J.-C. Guery
Estrogen Enhances Susceptibility to Experimental Autoimmune Myasthenia Gravis by Promoting Type 1-Polarized Immune Responses
J. Immunol., October 15, 2005; 175(8): 5050 - 5057.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Okumura, M. Iwai, A. Ide, M. Mogi, M. Ito, and M. Horiuchi
Sex Difference in Vascular Injury and the Vasoprotective Effect of Valsartan Are Related to Differential AT2 Receptor Expression
Hypertension, September 1, 2005; 46(3): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Stirone, S. P. Duckles, and D. N. Krause
Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen
Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E184 - E192.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H.-W. Liu, M. Iwai, Y. Takeda-Matsubara, L. Wu, J.-M. Li, M. Okumura, T.-X. Cui, and M. Horiuchi
Effect of Estrogen and AT1 Receptor Blocker on Neointima Formation
Hypertension, October 1, 2002; 40(4): 451 - 457.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. E. Gargett, M. Zaitseva, K. Bucak, S. Chu, P. J. Fuller, and P. A. W. Rogers
17{beta}-Estradiol Up-Regulates Vascular Endothelial Growth Factor Receptor-2 Expression in Human Myometrial Microvascular Endothelial Cells: Role of Estrogen Receptor-{alpha} and -{beta}
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4341 - 4349.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. S. Sherman, K. L. Chambliss, L. L. Gibson, M. C. Pace, M. E. Mendelsohn, S. L. Pfister, and P. W. Shaul
Estrogen Acutely Activates Prostacyclin Synthesis in Ovine Fetal Pulmonary Artery Endothelium
Am. J. Respir. Cell Mol. Biol., May 1, 2002; 26(5): 610 - 616.
[Abstract] [Full Text] [PDF]